FDA Inspection 1028320 — Amgen, Inc.

Amgen, Inc. — FEI 2026154

The FDA completed an inspection of Amgen, Inc. on August 21, 2017 in Thousand Oaks, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 21, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Thousand Oaks, CA (United States)